Anogenital warts and Respiratory Papillomatosis. Okay - $8m cash plus approx $9m worth of stock (10% of Market Cap), plus possible commissions and royalties subject to success. No comment.
VAP Phase 2b trial in moderate to severe Asthmatics.
Behind the bookcase (i.e. further away than the bottom drawer) till next year.
Anogenital warts and Respiratory Papillomatosis. Okay - $8m cash...
Add to My Watchlist
What is My Watchlist?